Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    JAMA network open · 2020
    DSDeirdre Sawinski
    PMID: 33165609PMCID: PMC7653497DOISenior author660 citations
  2. 2
    Journal of the American Society of Nephrology : JASN · 2023
    DSDeirdre Sawinski
    PMID: 36735375PMCID: PMC10103100DOISenior author4 citations
  3. 3
    Journal of bioethical inquiry · 2022
    DSDeirdre Sawinski
    PMID: 36472763DOIFirst author7 citations

Publications

158 publications

Funding

6 grantsView NIH portfolio on RePORTER ↗

Active

3 grants
  • Sub-PI
    5/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
    National Institute of Diabetes and Digestive and Kidney Diseases · 2022–2028 · via Columbia University· 2 renewals
    U01DK116066-08
  • Sub-PI
    Cardiovascular and Renal Protection with SGLT2 Inhibition in Kidney Transplant Recipients (RENAISSANCE)
    National Institute of Diabetes and Digestive and Kidney Diseases · 2025–2027 · via University of Minnesota
    U34DK141987-01
  • Sub-PI
    Estrogen and SERMS as Therapy for Renal Ischemia Reperfusion Injury
    National Institute of Diabetes and Digestive and Kidney Diseases · 2024–2026 · via University of Pennsylvania
    R01DK139679-02
Completed grants (3)
  • Sub-PI
    Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV
    National Institute of Diabetes and Digestive and Kidney Diseases · 2021–2024 · via The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
    R01DK117675-05
  • Sub-PI
    Identifying and exploring solutions to the ethical challenges of ApoL1 testing of donors with recent African ancestry through mixed methods research with stakeholders
    National Institute on Minority Health and Health Disparities · 2021–2024 · via Washington University, The
    R01MD014161-03
  • PI
    Waiting List and Kidney Transplant Outcomes for Patients with Hepatitis C Infection
    NIDDK · 2017–2021 · via NIH RePORTER
    R21DK108045-02

Clinical research

1 study

Active

1 study
  • PI
    The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
    PHASE2 · University of North Carolina at Chapel Hill · OPEN TO ACCRUAL (as of 2025)
    Kidney Transplant; Complications
    NCT06059664

News mentions

1 mentionView all WCM news ↗

External relationships

Advisory/Scientific Board Member

Biogen, Inc. · Eledon Pharmaceuticals INC · Invivyd INC · Sanofi S.A.

Other

Maze Therapeutics · United Therapeutics